Search

Background: Many studies in India and all over the world have focused on the psychological aspect of infertility in women, but only a few have explored it among men. To deal with psychological distress, sometimes, individuals may use maladaptive coping strategies which can further worsen the stress instead of reducing it. Aim: To assess symptoms of depression, anxiety, stress, and various coping strategies adopted by men with infertility along with exploring their coping experiences. Methods: A sequential explanatory mixed-method study was conducted in a tertiary care hospital in South India. The study was conducted among 200 men with infertility seeking treatment from a tertiary care hospital. The symptoms of depression, anxiety, and stress were assessed using Depression, Anxiety, Stress-21 scale, and coping strategies were assessed using Brief COPE scale. In-depth interviews were conducted among eight men who had moderate to severe symptoms of depression, anxiety, and stress. Results: The proportion of depressive symptoms was 46% (95% CI: 39.2–52.9), that of anxiety was 51% (95% CI: 44.1–57.8), and that of stress was 59.5% (95% CI: 52.5–66.0). The most common coping strategies used were planning (96.0%), active coping (91.5%), self-distraction (90.5%), and religion (89.5%). The analysis of qualitative data revealed three themes – emotional impact of infertility, coping mechanisms and support systems, and perception toward counseling to improve mental wellbeing. Conclusion: The study shows that the prevalence of symptoms of depression, anxiety, and stress is considerable among men with infertility. The majority of them were using problem-focused coping. Overall, the study highlights the need to diagnose and address mental health problems among men with infertility. [ABSTRACT FROM AUTHOR]

Schizophrenia in children is diagnosed by using adult criteria. Based on the age of onset, patients with childhood onset schizophrenia (COS) are subdivided into those with very early onset (before age 12-14 years) and those with early onset (between 14-17 years). The prevalence of COS is reported to be 1 in 10,000 before the age of 12 years; however, there is a significant increase around puberty and early adolescence and by 18 years of age, 20% of the patients with schizophrenia will have the illness. Simple delusions and hallucinations revolving around childhood themes, language and communication deficits and flat affect have been reported in COS. Follow-up studies suggest that the outcome is generally poor to fair. Predictors of poor outcome are age of onset (less than 12 years), insidious onset and marked premorbid abnormalities. (Contains 1 table.)

The article presents the discussion on neurons and reprogram your brain to lead a successful life. Topics include Neurolinguistic programming (NLP) or neurolinguistic programming therapy (NLPt) has made such promises recently, with questionable evidence; and facilitate modeling, elicit well-defined goals, and employ anchoring or conditioning techniques.

Attention-deficit/hyperactivity disorder (ADHD) is one of common neurodevelopmental disorder often comorbid with epilepsy. There are no existing guidelines on how to manage these two conditions when they are comorbid. To identify relationship between epilepsy and ADHD and to know role of antiepileptics and safety of stimulant like methylphenidate in such conditions from existing literature, we searched articles published in clinical journals available online between 1990-2010, with these key words in medline:children, epilepsy, seizure, comorbid, ADHD, treatment. Relevant abstracts were further selected for their focus on current topic. Cross references were extracted. Finally relevant articles that included original research articles, reviews and abstracts of non-english literature were used. Children with epilepsy may manifest with symptoms of ADHD. Children with ADHD may develop epilepsy. Some antiepileptics like phenobarbitone, gabapentin, topiramate may not be helpful in controlling behavioral symptoms of ADHD. Stimulants are the main stay of pharmacotherapy for ADHD but there is risk of decreasing seizure threshold in children with comorbid epilepsy especially when their epilepsy is not well controlled. Existing evidence is not in favor of screening children with ADHD for EEG abnormality before starting stimulant therapy.